Appscent vs CytoReason
Appscent vs CytoReason, compared side by side on 20 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Appscent is on 49/100 and CytoReason on 68/100.
Where each one leads
Appscent
- agent readiness: 42/100 against 21/100
- headcount growth: +51.0% against +13.7%
CytoReason
- our overall score: 68/100 against 49/100
- domain rating: 40/100 against 19/100
- headcount: 116 against 35
- funding raised: $128M against $1.0M
- LinkedIn following: 12,830 against 938
At a glance
| Measure | Appscent | CytoReason |
|---|---|---|
| What it is | AI-powered medical technology revolutionizing sleep apnea diagnosis and treatment. | Develops a computational model of the human body for drug discovery and development. |
| Category | Healthcare, Sleep, Apnea, Non-invasive | Healthcare, Drug Discovery, Clinical Development, Biomarkers |
| Sells toBusiness model | B2B | B2B |
| Offering | Hardware, Software | Software |
| Founded | 2018 | 2016 |
| Headquarters | Tel Aviv, Israel | Tel Aviv, Israel |
| Status | Active | Active |
Size, funding and growth
| Measure | Appscent | CytoReason |
|---|---|---|
| Employees | 35 | 116 |
| Headcount growthLast 12 months | +51.0% | +13.7% |
| Total funding | $1.0M | $128M |
| Latest round | Pre-Seed | Series B |
| LinkedIn followers | 938 | 12,830 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Appscent | CytoReason |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 49/100 | 68/100 |
| Traction | 46/100 | 60/100 |
| Team | 70/100 | 70/100 |
| Community | 8/100 | Not published |
| Search visibility | 36/100 | 30/100 |
| Quality | 48/100 | 78/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (42/100) | F (21/100) |
| Domain ratingLink authority, 0-100 | 19/100 | 40/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Appscent | CytoReason |
|---|---|---|
| CDN | Cloudflare | Not detected |
| CMS | Lovable | Not detected |
| Analytics | Google Analytics 4 | Segment |
Appscent vs CytoReason: common questions
Which is better, Appscent or CytoReason?
On our 0-100 score CytoReason rates higher (68/100 against 49/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 20 data points above: read the rows that match what you are buying for.
How do Appscent and CytoReason compare on the numbers?
Appscent leads on agent readiness (42/100 against 21/100), headcount growth (+51.0% against +13.7%). CytoReason leads on our overall score (68/100 against 49/100), domain rating (40/100 against 19/100), headcount (116 against 35), funding raised ($128M against $1.0M), LinkedIn following (12,830 against 938).
Read the full Appscent review and pricing or the CytoReason review and pricing. You can also browse other Appscent alternatives we track.